Showing results (401-410 of 476) with videos related to
Sort By:
Pageof 48
Journal of Bacteriology|September 1, 1990
Biosynthesis of anthraquinones by interspecies cloning of actinorhodin biosynthesis genes in streptomycetes: clarification of actinorhodin gene functionsP L Bartel, C B Zhu, J S Lampel, et al.European Journal of Cancer (Oxford, England : 1990)|April 28, 2024
Real-world treatment patterns and medical costs of prostate cancer patients in Switzerland - A claims data analysisMichael Stucki, Stephanie Dosch, Markus Gnädinger, et al.Langmuir : the ACS Journal of Surfaces and Colloids|December 21, 2016
Observation of Ultrathin Precursor Film Formation during Ge-Si Liquid-Phase Epitaxy from an Undersaturated SolutionVedran Vonk, Diego Pontoni, Melissa Cremers, et al.The Review of Scientific Instruments|January 12, 2010
A spin-echo resolved grazing incidence scattering setup for the neutron interrogation of buried nanostructuresJános Major, Alexei Vorobiev, Adrian Rühm, et al.Pediatric Diabetes|January 19, 2012
Growth differences between North American and European children at risk for type 1 diabetesAnita M Nucci, Dorothy J Becker, Suvi M Virtanen, et al.Cell Death & Disease|November 12, 2020
Stroma secreted IL6 selects for "stem-like" population and alters pancreatic tumor microenvironment by reprogramming metabolic pathwaysKousik Kesh, Vanessa T Garrido, Austin Dosch, et al.Proceedings of the National Academy of Sciences of the United States of America|September 26, 2007
Aquatic eutrophication promotes pathogenic infection in amphibiansPieter T J Johnson, Jonathan M Chase, Katherine L Dosch, et al.Zebrafish|September 30, 2010
Report of the European Zebrafish Principal Investigator Meeting in Padua, Italy, March 18–22, 2010Caroline Brennan, Roland Dosch, Anna-Pavlina Haramis, et al.Cell Death & Disease|April 7, 2021
Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injuryNicolas Melin, Daniel Sánchez-Taltavull, René Fahrner, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2011
Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in type 1 diabetesKevan C Herold, Mark D Pescovitz, Paula McGee, et al.Pageof 48